Proteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic
Fungal pathogens cause an array of diseases by targeting both immunocompromised and immunocompetent hosts. Fungi overcome our current arsenal of antifungals through the emergence and evolution of resistance. In particular, the human fungal pathogen, <i>Cryptococcus neoformans</i> is foun...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/27779c36e7b24c5a8e4b390eeb49ba93 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:27779c36e7b24c5a8e4b390eeb49ba93 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:27779c36e7b24c5a8e4b390eeb49ba932021-11-25T17:56:11ZProteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic10.3390/ijms2222123901422-00671661-6596https://doaj.org/article/27779c36e7b24c5a8e4b390eeb49ba932021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12390https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Fungal pathogens cause an array of diseases by targeting both immunocompromised and immunocompetent hosts. Fungi overcome our current arsenal of antifungals through the emergence and evolution of resistance. In particular, the human fungal pathogen, <i>Cryptococcus neoformans</i> is found ubiquitously within the environment and causes severe disease in immunocompromised individuals around the globe with limited treatment options available. To uncover fundamental knowledge about this fungal pathogen, as well as investigate new detection and treatment strategies, mass spectrometry-based proteomics provides a plethora of tools and applications, as well as bioinformatics platforms. In this review, we highlight proteomics approaches within the laboratory to investigate changes in the cellular proteome, secretome, and extracellular vesicles. We also explore regulation by post-translational modifications and the impact of protein–protein interactions. Further, we present the development and comprehensive assessment of murine models of cryptococcal infection, which provide valuable tools to define the dynamic relationship between the host and pathogen during disease. Finally, we explore recent quantitative proteomics studies that begin to extrapolate the findings from the bench to the clinic for improved methods of fungal detection and monitoring. Such studies support a framework for personalized medical approaches to eradicate diseases caused by <i>C. neoformans</i>.Ben MuseliusShay-Lynn DurandJennifer Geddes-McAlisterMDPI AGarticle<i>Cryptococcus neoformans</i>mass spectrometry-based proteomicsfungal pathogenesisin vitro and in vivo modelspersonalized medicineBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12390, p 12390 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
<i>Cryptococcus neoformans</i> mass spectrometry-based proteomics fungal pathogenesis in vitro and in vivo models personalized medicine Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
<i>Cryptococcus neoformans</i> mass spectrometry-based proteomics fungal pathogenesis in vitro and in vivo models personalized medicine Biology (General) QH301-705.5 Chemistry QD1-999 Ben Muselius Shay-Lynn Durand Jennifer Geddes-McAlister Proteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic |
description |
Fungal pathogens cause an array of diseases by targeting both immunocompromised and immunocompetent hosts. Fungi overcome our current arsenal of antifungals through the emergence and evolution of resistance. In particular, the human fungal pathogen, <i>Cryptococcus neoformans</i> is found ubiquitously within the environment and causes severe disease in immunocompromised individuals around the globe with limited treatment options available. To uncover fundamental knowledge about this fungal pathogen, as well as investigate new detection and treatment strategies, mass spectrometry-based proteomics provides a plethora of tools and applications, as well as bioinformatics platforms. In this review, we highlight proteomics approaches within the laboratory to investigate changes in the cellular proteome, secretome, and extracellular vesicles. We also explore regulation by post-translational modifications and the impact of protein–protein interactions. Further, we present the development and comprehensive assessment of murine models of cryptococcal infection, which provide valuable tools to define the dynamic relationship between the host and pathogen during disease. Finally, we explore recent quantitative proteomics studies that begin to extrapolate the findings from the bench to the clinic for improved methods of fungal detection and monitoring. Such studies support a framework for personalized medical approaches to eradicate diseases caused by <i>C. neoformans</i>. |
format |
article |
author |
Ben Muselius Shay-Lynn Durand Jennifer Geddes-McAlister |
author_facet |
Ben Muselius Shay-Lynn Durand Jennifer Geddes-McAlister |
author_sort |
Ben Muselius |
title |
Proteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic |
title_short |
Proteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic |
title_full |
Proteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic |
title_fullStr |
Proteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic |
title_full_unstemmed |
Proteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic |
title_sort |
proteomics of <i>cryptococcus neoformans</i>: from the lab to the clinic |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/27779c36e7b24c5a8e4b390eeb49ba93 |
work_keys_str_mv |
AT benmuselius proteomicsoficryptococcusneoformansifromthelabtotheclinic AT shaylynndurand proteomicsoficryptococcusneoformansifromthelabtotheclinic AT jennifergeddesmcalister proteomicsoficryptococcusneoformansifromthelabtotheclinic |
_version_ |
1718411790780465152 |